These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 12960235)

  • 1. Regulation of HIV-1 gene transcription: from lymphocytes to microglial cells.
    Rohr O; Marban C; Aunis D; Schaeffer E
    J Leukoc Biol; 2003 Nov; 74(5):736-49. PubMed ID: 12960235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tetraspanin CD81 provides a costimulatory signal resulting in increased human immunodeficiency virus type 1 gene expression in primary CD4+ T lymphocytes through NF-kappaB, NFAT, and AP-1 transduction pathways.
    Tardif MR; Tremblay MJ
    J Virol; 2005 Apr; 79(7):4316-28. PubMed ID: 15767432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influenza virus activates human immunodeficiency virus type-1 gene expression in human CD4-expressing T cells through an NF-kappaB-dependent pathway.
    Sun J; Bergeron M; Barbeau B; Boivin G; Tremblay MJ
    Clin Immunol; 2005 Feb; 114(2):190-8. PubMed ID: 15639653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repression of the human immunodeficiency virus type-1 long terminal repeat by the c-Myc oncoprotein.
    Stojanova A; Caro C; Jarjour RJ; Oster SK; Penn LZ; Germinario RJ
    J Cell Biochem; 2004 May; 92(2):400-13. PubMed ID: 15108364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the human immunodeficiency virus type I long terminal repeat by 1 alpha,25-dihydroxyvitamin D3.
    Nevado J; Tenbaum SP; Castillo AI; Sánchez-Pacheco A; Aranda A
    J Mol Endocrinol; 2007 Jun; 38(6):587-601. PubMed ID: 17556530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular latency in HIV-1 infection.
    Laughlin MA; Pomerantz RJ
    Clin Lab Med; 1994 Jun; 14(2):239-55. PubMed ID: 7924190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NF-kappaB-repressing factor inhibits elongation of human immunodeficiency virus type 1 transcription by DRB sensitivity-inducing factor.
    Dreikhausen U; Hiebenthal-Millow K; Bartels M; Resch K; Nourbakhsh M
    Mol Cell Biol; 2005 Sep; 25(17):7473-83. PubMed ID: 16107696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine modulation of HIV expression.
    Poli G; Fauci AS
    Semin Immunol; 1993 Jun; 5(3):165-73. PubMed ID: 7688596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromatin-associated regulation of HIV-1 transcription: implications for the development of therapeutic strategies.
    Quivy V; De Walque S; Van Lint C
    Subcell Biochem; 2007; 41():371-96. PubMed ID: 17484137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of transcription from the human immunodeficiency virus type 1 (HIV-1) long terminal repeat by the vasoactive intestinal peptide (VIP).
    Gilles A; Miquelis A; Luis J; Faure E
    Ital J Biochem; 1998 Jun; 47(2):101-10. PubMed ID: 9741048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Productive human immunodeficiency virus type 1 infection in peripheral blood predominantly takes place in CD4/CD8 double-negative T lymphocytes.
    Kaiser P; Joos B; Niederöst B; Weber R; Günthard HF; Fischer M
    J Virol; 2007 Sep; 81(18):9693-706. PubMed ID: 17609262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of octamer transcription factors 1 or 2 alone has no effect on HIV-1 transcription in primary human CD4 T cells.
    Zhang M; Genin A; Cron RQ
    Virology; 2004 Apr; 321(2):323-31. PubMed ID: 15051391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tat-dependent repression of human immunodeficiency virus type 1 long terminal repeat promoter activity by fusion of cellular transcription factors.
    Zhao C; Chen Y; Park J; Kim JB; Tang H
    Biochem Biophys Res Commun; 2004 Sep; 322(2):614-22. PubMed ID: 15325274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyamides reveal a role for repression in latency within resting T cells of HIV-infected donors.
    Ylisastigui L; Coull JJ; Rucker VC; Melander C; Bosch RJ; Brodie SJ; Corey L; Sodora DL; Dervan PB; Margolis DM
    J Infect Dis; 2004 Oct; 190(8):1429-37. PubMed ID: 15378435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 infection initiates changes in the expression of a wide array of genes in U937 promonocytes and HUT78 T cells.
    Wen W; Chen S; Cao Y; Zhu Y; Yamamoto Y
    Virus Res; 2005 Oct; 113(1):26-35. PubMed ID: 15885842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p27(SJ), a novel protein in St John's Wort, that suppresses expression of HIV-1 genome.
    Darbinian-Sarkissian N; Darbinyan A; Otte J; Radhakrishnan S; Sawaya BE; Arzumanyan A; Chipitsyna G; Popov Y; Rappaport J; Amini S; Khalili K
    Gene Ther; 2006 Feb; 13(4):288-95. PubMed ID: 16251997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Luman, a new partner of HIV-1 TMgp41, interferes with Tat-mediated transcription of the HIV-1 LTR.
    Blot G; Lopez-Vergès S; Treand C; Kubat NJ; Delcroix-Genête D; Emiliani S; Benarous R; Berlioz-Torrent C
    J Mol Biol; 2006 Dec; 364(5):1034-47. PubMed ID: 17054986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of human immunodeficiency virus type 1 gene expression and pathogenesis by CCAAT/enhancer binding proteins in cells of the monocyte/macrophage lineage.
    Hogan TH; Krebs FC; Wigdahl B
    J Neurovirol; 2002 Dec; 8 Suppl 2():21-6. PubMed ID: 12491147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NF-kappaB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation.
    Williams SA; Chen LF; Kwon H; Ruiz-Jarabo CM; Verdin E; Greene WC
    EMBO J; 2006 Jan; 25(1):139-49. PubMed ID: 16319923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent status of HIV-1 gene expression inhibitors.
    Baba M
    Antiviral Res; 2006 Sep; 71(2-3):301-6. PubMed ID: 16488488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.